In The Spotlight
DDNews Cancer Research Exclusive
 
 
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
 
(Photo credit: University of Toronto)
 
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
 
 
NEWS
Themis Bioscience plans to expand measles vector immunomodulation portfolio into oncology indications
 
The new additions give PanFAM-1, a prospective study pursuing early diagnosis in people with a high heredity risk of pancreatic cancer, a boost in the effort to validate Immunovia's IMMray PanCan-d test
 
DNA immunotherapy and checkpoint inhibitor combination lead to remission
 
Company completes validation of prostate cancer PDX model and forms alliance with Shanghai Model Organisms Center
 
MolecularMD validates Thermo Fisher assay that can help in trial stratification
 
October saw medical technology provider iCAD Inc. share clinical results for its new digital breast tomosynthesis cancer detection software
 
Research team publishes research on the anticancer effects of retinoic acid on cancer stem cells
 
A new collaboration agreement is underway between APEIRON Biologics AG and the Lead Discovery Center (LDC) GmbH
 
 
FEATURES
 

Columbia Business School report examines how cancer drugs have impacted mortality for patients
 
OPINION
by Dr. Eyal Talor, CEL-SCI
A look at what to expect from the second generation of cancer immunotherapies, after the progress--and pitfalls--of CAR-T cell therapies

by JK Bryan & A Zupnick, Novella
When it comes to oncology clinical trials, drug developers need to stay abreast of the rapidly evolving and competitive landscape while also remaining flexible and innovative in responding to these changes

by Dr. Alexey Eliseev, RXi
The “War on Cancer” declared by the National Cancer Act of 1971 proceeded through a series of evolutionary developments in chemotherapy, radiation treatments and targeted therapies, but until recently was only marginally successful in extending the lives of late-stage cancer patients. A major breakthrough has been achieved over the last decade with the development of immunotherapeutic treatments that empower a patient’s own immune cells to destroy tumors


 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.